These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 22906361)

  • 1. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity.
    Otto M
    Annu Rev Med; 2013; 64():175-88. PubMed ID: 22906361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of staphylococcal biofilm dispersal and structuring.
    Le KY; Dastgheyb S; Ho TV; Otto M
    Front Cell Infect Microbiol; 2014; 4():167. PubMed ID: 25505739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Phenol-Soluble Modulins in Staphylococcus epidermidis Biofilm Formation and Infection of Indwelling Medical Devices.
    Le KY; Villaruz AE; Zheng Y; He L; Fisher EL; Nguyen TH; Ho TV; Yeh AJ; Joo HS; Cheung GYC; Otto M
    J Mol Biol; 2019 Jul; 431(16):3015-3027. PubMed ID: 30954574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice.
    Wang R; Khan BA; Cheung GY; Bach TH; Jameson-Lee M; Kong KF; Queck SY; Otto M
    J Clin Invest; 2011 Jan; 121(1):238-48. PubMed ID: 21135501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal biofilms.
    Otto M
    Curr Top Microbiol Immunol; 2008; 322():207-28. PubMed ID: 18453278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenol-soluble modulins: novel virulence-associated peptides of staphylococci.
    Li S; Huang H; Rao X; Chen W; Wang Z; Hu X
    Future Microbiol; 2014; 9(2):203-16. PubMed ID: 24295365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.
    Schilcher K; Horswill AR
    Microbiol Mol Biol Rev; 2020 Aug; 84(3):. PubMed ID: 32792334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo.
    Vuong C; Kocianova S; Yao Y; Carmody AB; Otto M
    J Infect Dis; 2004 Oct; 190(8):1498-505. PubMed ID: 15378444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus quorum sensing in biofilm formation and infection.
    Kong KF; Vuong C; Otto M
    Int J Med Microbiol; 2006 Apr; 296(2-3):133-9. PubMed ID: 16487744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
    Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Staphylococcus aureus biofilms develop their characteristic structure.
    Periasamy S; Joo HS; Duong AC; Bach TH; Tan VY; Chatterjee SS; Cheung GY; Otto M
    Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1281-6. PubMed ID: 22232686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
    Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
    J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical significance and management of staphylococcal biofilm.
    Agarwal A; Singh KP; Jain A
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):147-60. PubMed ID: 19793317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of in vivo biofilm formation by bacterial pathogens.
    Joo HS; Otto M
    Chem Biol; 2012 Dec; 19(12):1503-13. PubMed ID: 23261595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis.
    Xu L; Li H; Vuong C; Vadyvaloo V; Wang J; Yao Y; Otto M; Gao Q
    Infect Immun; 2006 Jan; 74(1):488-96. PubMed ID: 16369005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci.
    Frank KL; Patel R
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):9-16. PubMed ID: 17889481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forces guiding staphylococcal adhesion.
    Herman-Bausier P; Formosa-Dague C; Feuillie C; Valotteau C; Dufrêne YF
    J Struct Biol; 2017 Jan; 197(1):65-69. PubMed ID: 26707623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenol-soluble modulins.
    Otto M
    Int J Med Microbiol; 2014 Mar; 304(2):164-9. PubMed ID: 24447915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
    Hou W; Sun X; Wang Z; Zhang Y
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.